Neonatal Ichthyosis-Sclerosing Cholangitis Syndrome (NISCS): A Patient Guide

Neonatal Ichthyosis-Sclerosing Cholangitis Syndrome (NISCS) is an exceptionally rare genetic condition that fundamentally changes how the body maintains its internal and external barriers. It is caused by a mutation in the CLDN1 gene, which is responsible for producing a protein called claudin-1 ^[1]. This protein acts as a vital component of “tight junctions,” the cellular seals that prevent leaks between cells and protect the structural integrity of the skin and the liver’s bile ducts. When these seals are faulty, the body’s protective barriers are compromised, leading to the complex symptoms that characterize this syndrome ^[2].

The most consistent, universally reported sign of NISCS is generalized ichthyosis, a condition where the skin appears dry, thickened, and scaly from birth ^[3]. This happens because the skin’s weakened barrier allows moisture to escape far too easily, which in infants can pose serious risks of dehydration and infection. Beyond the skin, the condition can variably affect other areas that rely on these cellular seals, sometimes leading to sparse hair (hypotrichosis) or hair loss, as well as unique differences in the shape and development of the teeth ^[4].

The liver involvement in NISCS, known as sclerosing cholangitis, is highly unpredictable. In some children, liver issues appear as jaundice or bile backup in infancy that eventually stabilizes. In others, the bile ducts can become progressively scarred, which may lead to more serious liver complications and portal hypertension over time ^[3]. Crucially, the severity of a child’s skin symptoms does not predict how their liver will behave; a child with very mild skin scaling may still face significant liver challenges ^[5]. Importantly, in any newborn, persistent jaundice or pale stools should never be treated as “wait and see” symptoms; they always require urgent medical evaluation.

Because of this unpredictability and the extreme rarity of the condition—with a historical review identifying only about 37 published cases worldwide as of late 2024—management requires a dedicated, lifelong partnership with a multidisciplinary medical team ^[3]. Specialists in dermatology and hepatology work together to monitor the skin’s health and track liver function through regular imaging and blood tests. While navigating a diagnosis this rare can feel daunting, consistent surveillance and personalized care allow families to stay ahead of potential complications and provide their children with the best possible support for a healthy future ^[3][4].